Multi-Organ Increase in Norepinephrine Levels after Central Leptin Administration and Diet-Induced Obesity.
fat
leptin
liver
norepinephrine
ovary
sympathetic nervous system
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 Nov 2023
29 Nov 2023
Historique:
received:
12
10
2023
revised:
17
11
2023
accepted:
22
11
2023
medline:
9
12
2023
pubmed:
9
12
2023
entrez:
9
12
2023
Statut:
epublish
Résumé
Autonomic innervation is important to regulate homeostasis in every organ of the body. The sympathetic nervous system controls several organs associated with metabolism and reproduction, including adipose tissue, the liver, and the ovaries. The sympathetic nervous system is controlled within the central nervous system by neurons located in the hypothalamus, which in turn are regulated by hormones like leptin. Leptin action in the hypothalamus leads to increased sympathetic activity in the adipose tissue. In this short report, we propose that leptin action in the brain also controls the sympathetic innervation of other organs like the liver and the ovary. We performed two experiments: We performed an intracerebroventricular (ICV) injection of leptin and measured norepinephrine levels in several organs, and we used a validated model of overnutrition and obesity to evaluate whether an increase in leptin levels coexists with high levels of norepinephrine in the liver and ovaries. Norepinephrine was measured by ELISA in adipose tissue and by HPLC-EC in other tissues. Leptin was measured by ELISA. We found that the ICV injection of leptin increases norepinephrine levels in several organs, including the liver and ovaries. Also, we found that diet-induced obesity leads to an increase in leptin levels while inducing an increase in norepinephrine levels in the liver and ovaries. Finally, since hyperactivity of the sympathetic nervous system is observed both in non-alcoholic fatty liver disease and polycystic ovary syndrome, we think that an increase in norepinephrine levels induced by hyperleptinemia could be involved in the pathogenesis of both diseases.
Identifiants
pubmed: 38069231
pii: ijms242316909
doi: 10.3390/ijms242316909
pmc: PMC10706686
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : FONDECYT- ANID
ID : 1201816
Références
J Hum Reprod Sci. 2018 Oct-Dec;11(4):343-347
pubmed: 30787518
BMC Med. 2023 Feb 20;21(1):62
pubmed: 36800955
Int J Mol Sci. 2021 Apr 19;22(8):
pubmed: 33921881
Vitam Horm. 1998;54:1-30
pubmed: 9529971
Endocrinology. 2013 Sep;154(9):3387-400
pubmed: 23751873
Front Endocrinol (Lausanne). 2021 Nov 08;12:752944
pubmed: 34819920
Lancet Diabetes Endocrinol. 2015 Mar;3(3):207-15
pubmed: 25066177
Anat Rec A Discov Mol Cell Evol Biol. 2004 Sep;280(1):854-67
pubmed: 15382015
Physiol Rev. 2018 Oct 1;98(4):2349-2380
pubmed: 30109817
J Hepatol. 2023 May;78(5):1048-1062
pubmed: 36740049
Endocrinology. 2008 Jan;149(1):50-6
pubmed: 17947351
J Biol Chem. 2000 Oct 20;275(42):33059-67
pubmed: 10938091
Sci Rep. 2020 Aug 17;10(1):13898
pubmed: 32807904
Endocrinology. 1993 Dec;133(6):2690-5
pubmed: 7902268
Biol Reprod. 2003 Jun;68(6):2038-43
pubmed: 12606413
Ann Noninvasive Electrocardiol. 2006 Oct;11(4):306-12
pubmed: 17040278
Endocrinology. 1990 Nov;127(5):2199-209
pubmed: 1977580
J Pediatr Endocrinol Metab. 2022 Feb 16;35(4):481-487
pubmed: 35170267
Physiol Rep. 2021 Jul;9(13):e14958
pubmed: 34231324
Front Neuroendocrinol. 2018 Jan;48:37-49
pubmed: 28754629
J Physiol. 2019 Sep;597(17):4565-4580
pubmed: 31278754
Anat Rec A Discov Mol Cell Evol Biol. 2004 Sep;280(1):808-20
pubmed: 15382020
Front Endocrinol (Lausanne). 2022 Mar 09;13:845165
pubmed: 35355566
Endocrinology. 1993 Dec;133(6):2696-703
pubmed: 8243293
J Endocrinol. 2020 Oct;247(1):69-85
pubmed: 32755996
J Neurochem. 2023 May;165(4):467-486
pubmed: 36648204
Endocrinology. 2008 Jun;149(6):2907-16
pubmed: 18308852
Curr Opin Endocrinol Diabetes Obes. 2013 Aug;20(4):335-41
pubmed: 23807606
Endocr Rev. 2017 Aug 1;38(4):267-296
pubmed: 28898979
Trends Endocrinol Metab. 2022 Mar;33(3):206-217
pubmed: 35063326
Aliment Pharmacol Ther. 2017 Jun;45(11):1403-1412
pubmed: 28370150
Lancet Diabetes Endocrinol. 2022 Sep;10(9):668-680
pubmed: 35934017
Endocrinology. 2011 Sep;152(9):3396-408
pubmed: 21712362
Cell Metab. 2021 Mar 2;33(3):666-675.e4
pubmed: 33545051
Endocrinology. 2003 Oct;144(10):4289-97
pubmed: 12960066
Metabolism. 2015 Jan;64(1):79-91
pubmed: 25467843
Cell Metab. 2013 Jul 2;18(1):29-42
pubmed: 23770129
J Endocrinol. 2019 Aug;242(2):115-124
pubmed: 31176305
Endocrine. 2009 Oct;36(2):179-88
pubmed: 19418269
Clin Endocrinol (Oxf). 2012 Dec;77(6):791-801
pubmed: 22882204
Cell Metab. 2020 Dec 1;32(6):951-966.e8
pubmed: 33080217
Endocrinology. 2012 Jun;153(6):2861-9
pubmed: 22334715
Nutr Diabetes. 2017 Apr 10;7(4):e260
pubmed: 28394360
Am J Physiol Regul Integr Comp Physiol. 2008 May;294(5):R1445-52
pubmed: 18321949
Methods Mol Biol. 2018;1732:433-448
pubmed: 29480491
J Neuroendocrinol. 2006 May;18(5):367-76
pubmed: 16629836
Microsc Res Tech. 2002 Dec 15;59(6):495-502
pubmed: 12467025
Endocrine. 2001 Jul;15(2):187-92
pubmed: 11720244